Annotations
Disease Ontology
disease by infectious agent (DOID:0050117)
A disease that is the consequence of the presence of pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, and aberrant proteins known as prions.|DO:wk
Table Filters- ACE2 inhibition leads to pulmonary fibrosis - WP5035 (Homo sapiens)
- Activation of NLRP3 inflammasome by SARS-CoV-2 - WP4876 (Homo sapiens)
- Acute viral myocarditis - WP4298 (Homo sapiens)
- Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway - WP5113 (Homo sapiens)
- Biosynthesis of the three types of mycolic acids - WP4198 (Mycobacterium tuberculosis)
- COVID-19 adverse outcome pathway - WP4891 (Homo sapiens)
- COVID-19 and endothelial cell senescence - WP5256 (Homo sapiens)
- COVID-19 structural coverage map - WP5145 (Homo sapiens)
- COVID-19, thrombosis and anticoagulation - WP4927 (Homo sapiens)
- Cell-type dependent selectivity of CCK2R signaling - WP3679 (Homo sapiens)
- Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway) - WP5148 (Homo sapiens)
- Crystal toxin triggered necrosis pathway - WP3648 (Caenorhabditis elegans)
- Cytosolic DNA-sensing pathway - WP4655 (Homo sapiens)
- Dengue-2 interactions with complement and coagulation cascades - WP3896 (Homo sapiens)
- Deregulation of renin-angiotensin system by SARS-CoV infection - WP4965 (Mus musculus)
- Downregulation of ACE2 by SARS-CoV-2 spike protein - WP4799 (Homo sapiens)
- Dual hijack model of Vif in HIV infection - WP3300 (Homo sapiens)
- Ebola virus infection in host - WP4217 (Homo sapiens)
- Endoplasmic reticulum stress response in coronavirus infection - WP4861 (Homo sapiens)
- Extrafollicular and follicular B cell activation by SARS-CoV-2 - WP5218 (Homo sapiens)
- FOXP3 in COVID-19 - WP5063 (Homo sapiens)
- Hepatitis B infection - WP4666 (Homo sapiens)
- Hijack of ubiquitination by SARS-CoV-2 - WP4860 (Homo sapiens)
- Host-pathogen interaction of human coronaviruses - MAPK signaling - WP4877 (Homo sapiens)
- Host-pathogen interaction of human coronaviruses - apoptosis - WP4864 (Homo sapiens)
- Host-pathogen interaction of human coronaviruses - autophagy - WP4863 (Homo sapiens)
- Host-pathogen interaction of human coronaviruses - interferon induction - WP4880 (Homo sapiens)
- Immune response to tuberculosis - WP4197 (Homo sapiens)
- Initiation of transcription and translation elongation at the HIV-1 LTR - WP3414 (Homo sapiens)
- Isoprenoid precursor biosynthesis in Pf apicoplasts - WP2918 (Plasmodium falciparum)
- LDLRAD4 and what we know about it - WP4904 (Homo sapiens)
- Linoleic acid metabolism affected by SARS-CoV-2 - WP4853 (Homo sapiens)
- Lung pathology of COVID-19 - WP5146 (Homo sapiens)
- MAPK and NFkB signaling pathways inhibited by Yersinia YopJ - WP3849 (Homo sapiens)
- Measles virus infection - WP4630 (Homo sapiens)
- Mitochondrial immune response to SARS-CoV-2 - WP5038 (Homo sapiens)
- Network map of SARS-CoV-2 signaling pathway - WP5115 (Homo sapiens)
- Non-classical role of vitamin D - WP5133 (Homo sapiens)
- Novel intracellular components of RIG-I-like receptor pathway - WP3865 (Homo sapiens)
- Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex - WP4884 (Homo sapiens)
- Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins - WP4936 (Homo sapiens)
- Prostaglandin signaling - WP5088 (Homo sapiens)
- RAS and bradykinin pathways in COVID-19 - WP4969 (Homo sapiens)
- ROS in COVID-19 endothelial dysfunction - WP5258 (Homo sapiens)
- Resistin as a regulator of inflammation - WP4481 (Homo sapiens)
- SARS coronavirus and innate immunity - WP4912 (Homo sapiens)
- SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation - WP5116 (Homo sapiens)
- SARS-CoV-2 altering angiogenesis via NRP1 - WP5065 (Homo sapiens)
- SARS-CoV-2 and ACE2 receptor: molecular mechanisms - WP4883 (Homo sapiens)
- SARS-CoV-2 and COVID-19 pathway - WP4846 (Homo sapiens)
- SARS-CoV-2 innate immunity evasion and cell-specific immune response - WP5039 (Homo sapiens)
- SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction - WP5183 (Homo sapiens)
- SARS-CoV-2 replication organelle formation - WP5156 (Homo sapiens)
- STING pathway in Kawasaki-like disease and COVID-19 - WP4961 (Homo sapiens)
- Soluble ACE2-mediated cell entry of SARS-CoV-2 - WP5076 (Homo sapiens)
- T-cell activation SARS-CoV-2 - WP5098 (Homo sapiens)
- T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection - WP3863 (Homo sapiens)
- Type I interferon induction and signaling during SARS-CoV-2 infection - WP4868 (Homo sapiens)
- Vitamin D in inflammatory diseases - WP4482 (Homo sapiens)
- mRNA vaccine activation of dendritic cell and induction of IFN-1 - WP5187 (Homo sapiens)
- nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell - WP5027 (Homo sapiens)